Adagio Medical Holdings, INC Form 4 insider transactions

Adagio Medical gains FDA approval to increase study sites and subjects for its pivotal cryoablation study, marking a significant step towards potential market approval.

Adagio Medical's ultra-low temperature cryoablation system for ventricular tachycardia has received CE Mark approval and is set for immediate commercialization in select European centers.